Category: Abbott LaboratoriesSyndicate content

J&J's $7B claim against Boston Scientific goes to the judge

January 22, 2015 by MassDevice

A federal judge will decide whether Boston Scientific owes more than $7 billion to Johnson & Johnson over J&J's jilting by Guidant Corp.

J&J's $7B claim against Boston Scientific goes to the judge

Ishrak: 'With COV We'll do for ORs what we've done for cath labs' | The week in medtech M&A

January 14, 2015 by MassDevice

Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'; Medtronic details shareholder votes for Covidien merger; CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014; Medtronic-Covidien merger could close this month; Covidien's Stellarex drug-eluting balloon wins CE Mark

Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'

January 12, 2015 by Brian Johnson

CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014

January 7, 2015 by Brian Johnson

Four medtech companies make CB Insights list of the top 20 venture capital-backed healthcare exits of 2014.

CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014

At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Abbott closes $250m Topera buyout

December 23, 2014 by Brad Perriello

Abbott says it closed the $250 million buyout of Topera Medical and its cardiac arrhythmia mapping technology.

Abbott closes $250m Topera buyout

Abbott (NYSE:ABT) said yesterday that it closed its acquisition of Topera Medical, paying $250 million up front and placing another unspecified amount on the table in performance-based milestones.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Guidant didn't breach deal with J&J, says lawyer | Medtech legal news for the week of December 22, 2014

December 22, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Lawyer says Guidant didn't breach deal with J&J; Ex-Abbott stent liaison alleges retaliation for compliance complaint; Trial date set for Boston Scientific executive's accused killer; Analogic expects fines in BK Medical's Danish bribery beef; SEC dings Bruker in $2.4m China bribery case

Report: Lawyer says Guidant didn't breach deal with J&J

December 16, 2014 by Brad Perriello

YYmeta

Ex-Abbott stent liaison alleges retaliation for compliance complaint

December 17, 2014 by Brad Perriello

A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.

Ex-Abbott stent liaison alleges retaliation for compliance complaint

Get the complete picture with a MassDevice Plus membership. Registered users can login here.